Healthy Volunteers Study
NCT06962059 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-02-05
Summary
The purpose of this study is to examine the role of the bacterial environments and metabolites in the early detection and prediction of ovarian cancer development. Vaginal swabs and stool samples will be collected from healthy volunteers, or those without a known ovarian cancer diagnosis or genetic ovarian cancer risk. These samples will be compared to samples from participants with increased cancer risk and ovarian cancer diagnoses.
Conditions
- Ovarian Cancer
- Genetic Predisposition to Disease
Interventions
- OTHER
-
Self-Administered Sample Collection
Participants will collect vaginal swabs and a stool sample.
Sponsors & Collaborators
-
Abramson Cancer Center at Penn Medicine
lead OTHER
Principal Investigators
-
Susan Domchek, MD · University of Pennsylvania
Eligibility
- Min Age
- 30 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-04-21
- Primary Completion
- 2027-01-15
- Completion
- 2027-05-25
Countries
- United States
Study Locations
More Related Trials
-
Research Study in Patients With Advanced Ovarian Epithelial Cancer
NCT00053235 ·Status: WITHDRAWN
-
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
NCT04794322 ·Status: RECRUITING
-
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
NCT00043472 ·Status: COMPLETED
-
Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
NCT00005025 ·Status: UNKNOWN ·Phase: PHASE2
-
Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
NCT01295489 ·Status: COMPLETED
-
Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer
NCT03656809 ·Status: COMPLETED
-
Appraising Medical Trial Experiences of Ovarian Cancer Patients
NCT05801796 ·Status: NOT_YET_RECRUITING
-
Study of Circulating Tumoral DNA in Ovarian Cancer
NCT01350908 ·Status: COMPLETED ·Phase: NA
-
Women Surviving Ovarian Cancer
NCT00596349 ·Status: COMPLETED
-
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
NCT02973750 ·Status: COMPLETED
-
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT00801320 ·Status: COMPLETED ·Phase: NA
-
Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
NCT00757263 ·Status: UNKNOWN
-
A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy
NCT06240598 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
NCT06290193 ·Status: RECRUITING ·Phase: PHASE2
-
Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
NCT06800105 ·Status: RECRUITING
-
Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases
NCT01048814 ·Status: COMPLETED
-
Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer
NCT00900523 ·Status: COMPLETED
-
Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer
NCT03606486 ·Status: TERMINATED ·Phase: NA
-
ChemoFx® PRO - A Post-Market Data Collection Study
NCT00669422 ·Status: TERMINATED
-
Ovarian Cancer Vaccine for Patients in Remission
NCT01068509 ·Status: COMPLETED ·Phase: PHASE2
-
Ovarian Screening Study
NCT00267072 ·Status: COMPLETED
-
Neoadjuvant Therapy for Ovarian Cancer
NCT01146795 ·Status: COMPLETED ·Phase: PHASE2
-
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
NCT00003794 ·Status: TERMINATED
-
Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
NCT06613230 ·Status: COMPLETED
-
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
NCT00757952 ·Status: COMPLETED